Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Single-Cell Transcriptional Landscapes of Human Bone Marrow Reveal Distinct Erythroid Phenotypes Underpinned By Genotype in Diamond-Blackfan Anemia

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-141535

Published: 2020

Journal Articles

Analyzing Efficacy Outcomes from the Phase 2 Study of Single-Agent Tazemetostat As Third-Line Therapy in Patients with Relapsed or Refractory Follicular Lymphoma to Identify Predictors of Response

Blood (2020) 136 (Supplement 1): 47–49.

https://doi.org/10.1182/blood-2020-137245

Published: 2020

Journal Articles

Updated Report on Identification of Molecular Predictors of Tazemetostat Response in an Ongoing NHL Phase 2 Study

Blood (2018) 132 (Supplement 1): 4097.

https://doi.org/10.1182/blood-2018-99-115132

Published: 2018

Journal Articles

Incidence and Risk Factors for Second Malignancies after Transplant in Long Term Survivors of Allogeneic Haematopoietic Stem Cell Transplant: A Single Centre Experience

Mohammed Snober, Richard Syzdlo, PhD, Jane Apperley, MB ChB MD, Aristeidis Chaidos, MD PhD, Edward Kanfer, PhD, Dragana Milojkovic, MBBS, PhD, Eduardo Olavarria, MD PhD, Renuka Palanicawandar, MD MRCP, FRCPath, Jiri Pavlu, MD MRCP, FRCPath, Jeannie F Todd, PhD, Nina Salooja, MD

Blood (2018) 132 (Supplement 1): 3417.

https://doi.org/10.1182/blood-2018-99-114229

Published: 2018

Journal Articles

Clustering Analysis of Myeloma Clone Phenotype Is Informative for Disease Heterogeneity and Prognosis at Relapse

Syeda Maheen Ahsan, Elisabet Nadal-Melsio, MD, Mark E Robinson, PhD, Richard Syzdlo, PhD, Eva Yebra-Fernandez, MD, Holger W Auner, MD PhD, Maria Atta, MD, Marco Bua, MD, Farah O'Boyle, PhD, Kikkeri Naresh, Jane Apperley, MB ChB MD, Anastasios Karadimitris, FRCPath, PhD, Aristeidis Chaidos, MD PhD

Blood (2018) 132 (Supplement 1): 4492.

https://doi.org/10.1182/blood-2018-99-117460

Published: 2018

Journal Articles

A Phase I Study of Molibresib (GSK525762), a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of a Phase I/II Open Label Single Agent Study in Subjects with Non-Hodgkin's Lymphoma (NHL)

Blood (2018) 132 (Supplement 1): 1682.

https://doi.org/10.1182/blood-2018-99-117089

Published: 2018

Journal Articles

Myeloma Cell Addiction to the Transcription Factor TCF11

Valentina Caputo, PhD, Katerina Goudevenou, PhD, Nikolaos Trasanidis, BSc, MSc, Kyriaki Petevi, MD, Xiaolin Xiao, PhD, Kanagaraju Ponnusamy, PhD, Deena Iskander, MD, David Pitcher, PhD, Antonia Rotolo, MD, Holger W. Auner, MD PhD, Aristeidis Chaidos, MD PhD, Anastasios Karadimitris, PhD

Blood (2017) 130 (Supplement 1): 1194.

https://doi.org/10.1182/blood.V130.Suppl_1.1194.1194

Published: 2017

Journal Articles

A Phase I Study of GSK525762, a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of Phase I/II Open Label Single Agent Study in Patients with Acute Myeloid Leukemia (AML)

Blood (2017) 130 (Supplement 1): 1377.

https://doi.org/10.1182/blood.V130.Suppl_1.1377.1377

Published: 2017

Journal Articles

Clinical Drug Resistance Linked to Inter-Convertible Phenotypic and Functional States of Tumor-Propagating Cells in Multiple Myeloma.

Blood (2012) 120 (21): 2909.

https://doi.org/10.1182/blood.V120.21.2909.2909

Published: 2012

Journal Articles

Autoreactive T Cells From Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Specifically Recognize Glycosyl- Phosphatidyl-Inositol (GPI)

Lucia Gargiulo, PhD, Michela Sica, PhD, Maria Papaioannou, MD, PhD, Giulia Talini, PhD, Aristeidis Chaidos, MD, PhD, Barbara Richichi, PhD, Andrei V Nikolaev, PhD, Cristina Nativi, PhD, Mark Layton, MD, Josu de la Fuente, MRCP, MRCPCH, FRCPath, Irene Roberts, Lucio Luzzatto, MD, FRCP, FRCPath, Rosario Notaro, MD, Anastasios Karadimitris, MD, PhD

Blood (2012) 120 (21): 647.

https://doi.org/10.1182/blood.V120.21.647.647

Published: 2012

Journal Articles

Contrasting Effects of Enhanced Sirt1 Activity in Normal and BCR-ABL1-Depedent Haematopoiesis

Ming Hu, PhD, Jamshid S Khorashad, MD, PhD, Aristeidis Chaidos, MD, PhD, Georgios Nteliopoulos, PhD, Mattaka Khongkow, Ms, Irene Roberts, John Goldman, DM, FRCP, FRCPath, FMedSci, Alistair Reid, PhD, Eric W-.F. Lam, PhD, Jane Apperley, Anastasios Karadimitris, MD, PhD

Blood (2012) 120 (21): 1215.

https://doi.org/10.1182/blood.V120.21.1215.1215

Published: 2012

Journal Articles

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome

Alice Norton, MB, Georgina Hall, BSc, PhD, MBBS, FRCP, FRCPath, Helen Richmond, RN, Anindita Roy, MB, Gillian Cowan, PhD, Kate Alford, PhD, Keelin O'Donoghue, MB, PhD, Oliver Tunstall, MB, PhD, Aristeidis Chaidos, MD, PhD, Anastasios Karadimitris, MD, PhD, Paresh Vyas, MB, PhD, Irene Roberts, MD

Blood (2010) 116 (21): 876.

https://doi.org/10.1182/blood.V116.21.876.876

Published: 2010

Journal Articles

High Frequency and Cell Dose of Invariant NKT Cells In the Graft Are Associated with Lack of Clinically Significant Acute Gvhd In T Cell-Replete Sibling Allografts

Aristeidis Chaidos, MD, PhD, Richard M. Szydlo, Edward J. Kanfer, Francesco Dazzi, Donald H. MacDonald, David Marin, MD, FRCP, Dragana Milojkovic, Jiri Pavlu, John Davis, PhD, Katayoun Rezvani, MD, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Irene Roberts, MD, Jane F. Apperley, Anastasios Karadimitris

Blood (2010) 116 (21): 2539.

https://doi.org/10.1182/blood.V116.21.2539.2539

Published: 2010

Journal Articles

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.

Ke Xu, MD, Aristotelis Antonopoulos, PhD, Emmanouil Spanoudakis, MD, PhD, Simon Parry, PhD, Aristeidis Chaidos, MD, PhD, Ming Hu, PhD, Terry Butters, PhD, Anne Dell, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Nikki Horwood, PhD, Anastasios Karadimitris, PhD, MRCP, FRCPath

Blood (2009) 114 (22): 424.

https://doi.org/10.1182/blood.V114.22.424.424

Published: 2009

Journal Articles

Second Autologous Stem Cell Transplantation Is Effective Salvage Therapy for Relapsed Multiple Myeloma.

Aristeidis Chaidos, MD, PhD, Chrissy Giles, B.A.(Hons), Holger W Auner, Marco Bua, Jiri Pavlu, Ellena Smith, Edward Kanfer, MD, Donald MacDonald, Jane F. Apperley, MBChB, FRCP, FRCPath, Amin Rahemtulla, MBBS, PhD, FRCP

Blood (2009) 114 (22): 1229.

https://doi.org/10.1182/blood.V114.22.1229.1229

Published: 2009

NARROW

Single-Cell Transcriptional Landscapes of Human Bone Marrow Reveal Distinct Erythroid Phenotypes Underpinned By Genotype in Diamond-Blackfan Anemia

Analyzing Efficacy Outcomes from the Phase 2 Study of Single-Agent Tazemetostat As Third-Line Therapy in Patients with Relapsed or Refractory Follicular Lymphoma to Identify Predictors of Response

Updated Report on Identification of Molecular Predictors of Tazemetostat Response in an Ongoing NHL Phase 2 Study

Incidence and Risk Factors for Second Malignancies after Transplant in Long Term Survivors of Allogeneic Haematopoietic Stem Cell Transplant: A Single Centre Experience

Clustering Analysis of Myeloma Clone Phenotype Is Informative for Disease Heterogeneity and Prognosis at Relapse

A Phase I Study of Molibresib (GSK525762), a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of a Phase I/II Open Label Single Agent Study in Subjects with Non-Hodgkin's Lymphoma (NHL)

Myeloma Cell Addiction to the Transcription Factor TCF11

A Phase I Study of GSK525762, a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of Phase I/II Open Label Single Agent Study in Patients with Acute Myeloid Leukemia (AML)

Clinical Drug Resistance Linked to Inter-Convertible Phenotypic and Functional States of Tumor-Propagating Cells in Multiple Myeloma.

Autoreactive T Cells From Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Specifically Recognize Glycosyl- Phosphatidyl-Inositol (GPI)

Contrasting Effects of Enhanced Sirt1 Activity in Normal and BCR-ABL1-Depedent Haematopoiesis

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome

High Frequency and Cell Dose of Invariant NKT Cells In the Graft Are Associated with Lack of Clinically Significant Acute Gvhd In T Cell-Replete Sibling Allografts

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.

Second Autologous Stem Cell Transplantation Is Effective Salvage Therapy for Relapsed Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only